Searcharxiv⌕ Search

arXiv · 2611.22907

Optimising Recruitment and Sample Allocation in Multi-Site Rare Disease Studies

Abstract

Clinical research in rare diseases is challenged by the limited availability and broad geographical distribution of eligible patients. This necessitates multi-centre collaboration and strategic selection of analytical laboratories based on capacity, cost, and capability. We present a mathematical framework based on cardinality optimisation to support key operational decisions in study design, balancing clinical relevance, feasibility, budgetary constraints, and logistical factors. The framework was implemented in the Reconstruction and Computational Modelling for Inherited Metabolic Diseases (Recon4IMD) project, aiming to recruit 1,900 diagnosed patients across 24 healthcare centres and eight metabolomic laboratories. Compared to both proportional heuristic and greedy marginal allocation baselines, the proposed optimisation model consistently achieved higher recruitment yields in simulated multi-centre scenarios and reduced metabolomic analysis costs by approximately 30% under unconstrained conditions. Notably, both the heuristic and greedy allocation baselines became infeasible under progressively tighter laboratory capacity constraints, whereas the optimised model maintained feasibility and cost control. These findings highlight the value of integrated optimisation strategies for improving recruitment, platform selection, and sample allocation in complex, resource-limited research settings.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Farid Zare, Catherine Clancy, Tal Dattner, Martina Messina, Julian Teinert, Jack McGoldrick, Pavel Ješina, Sabine Weller Grønborg, Ute Spiekerkoetter, James J O'Byrne, Trine Tangeraas, Maria Luz Couce, José A. Cocho, Javier de las Heras, Niklas Darin, Dorothea Möslinger, Peter Witters, Ina Knerr, Giancarlo La Marca, Ans T. van der Ploeg, Hidde H. Huidekoper, Terry G. J. Derks, Francjan J. van Spronsen, Sandra D. K Kingma, Anibh M. Das, Carlo Dionisi-Vici, Clara D. van Karnebeek, Julia B. Hennermann, Siobhán O'Sullivan, Sabine A. Fuchs, Luciana Hannibal, M. Rebecca Heiner-Fokkema, Marek J. Noga, Irene M. L. W. Körver-Keularts, Katja Benedikte Prestø Elgstøen, George J. G. Ruijter, J J M Jans, Amy Harms, Thomas Hankemeier, Maurizio Scarpa, Ines Thiele, Shamima Rahman, Stefan Kölker, Ronan M. T. Fleming. 2026-11-17. Optimising Recruitment and Sample Allocation in Multi-Site Rare Disease Studies. https://searcharxiv.com/abs/2611.22907

Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite Searcharxiv by Indiciae: BibTeX · RIS.

KEEP EXPLORING

Related papers

Analysis choices can produce apparent rich-club differences: an Alzheimer's disease EEG case study

Background: The weighted rich-club coefficient tests whether a network's most strongly connected nodes are preferentially interconnected. Its interpretation depends on two often-implicit choices: how the randomised comparison networks are constructed, and whether the hubs are re-identified in each comparison network or held fixed at those of the observed network. When hubs are defined by connection strength, these choices change what the coefficient tests. New method: We examined how these choices affect inference using resting-state EEG from 20 people with Alzheimer's disease and 20 controls. Holding the data fixed, we compared four analysis pipelines, crossing two ways of building the comparison networks (global weight reshuffle or strength-conditioned null) with the two hub choices, and ran a calibration study using data constructed to contain no preferential hub coupling beyond nodal strength. Results: An apparent eyes-open group difference in rich-club organisation appeared only under the pipeline combining a global weight reshuffle with re-identified hubs. Under the empirical resampling ensemble, that pipeline reported a group difference in 43% of pseudo-studies, always higher in the Alzheimer's disease group, while the other three stayed near the expected 5%. Comparison with existing methods: Unlike global weight reshuffling, strength-conditioned nulls approximately preserve nodal strengths; fixing observed hubs also retains the identity of the core being tested. Conclusions: The same data can support or dissolve an apparent rich-club difference depending on these choices. No single choice is universally correct, but reporting which were made, and why they fit the question being asked, is essential to interpreting the result.

q-bio.QM↗

Quantum Cognition Machine Learning for Forecasting Chromosomal Instability

The accurate prediction of chromosomal instability from the morphology of circulating tumor cells (CTCs) enables real-time detection of CTCs with high metastatic potential in the context of liquid biopsy diagnostics. However, it presents a significant challenge due to the high dimensionality and complexity of single-cell digital pathology data. Here, we introduce the application of Quantum Cognition Machine Learning (QCML), a quantum-inspired computational framework, to estimate morphology-predicted chromosomal instability in CTCs from patients with metastatic breast cancer. QCML leverages quantum mechanical principles to represent data as state vectors in a Hilbert space, enabling context-aware feature modeling, dimensionality reduction, and enhanced generalization without requiring curated feature selection. QCML outperforms conventional machine learning methods when tested on out of sample verification CTCs, achieving higher accuracy in identifying predicted large-scale state transitions (pLST) status from CTC-derived morphology features. These preliminary findings support the application of QCML as a novel machine learning tool with superior performance in high-dimensional, low-sample-size biomedical contexts. QCML enables the simulation of cognition-like learning for the identification of biologically meaningful prediction of chromosomal instability from CTC morphology, offering a novel tool for CTC classification in liquid biopsy.

q-bio.QM↗

What makes vertical federated learning work with thirteen samples? A controlled benchmark on coral thermal-stress multi-omics

Vertical federated learning (VFL) lets laboratories that hold different omics layers of the same samples train a joint model without sharing raw data, but it is usually developed for datasets with thousands of samples. We benchmarked VFL on a Montipora capitata thermal-stress dataset with 13 samples and 90,579 features across transcriptomics, proteomics, metabolomics and microbiome data. The benchmark crosses two VFL backbones (a split-network model implemented in NVIDIA FLARE, and LASER-VFL) with three per-silo feature-selection strategies (gradient saliency, random, univariate t-test) and two allocations of a 1,300-feature budget, and adds a centralised elastic-net reference. All models were trained for the same number of steps and evaluated by repeated stratified 3-fold and leave-one-out cross-validation, with separate estimates of seed and data-split variability and end-to-end label-permutation tests. Plain VFL on all features classified heat stress well above chance (3-fold AUROC 0.869, 95% CI 0.838-0.895; permutation p = 0.020). Gradient-saliency selection with hand-set omics priors (0.904) could not be distinguished from plain VFL, from equal budgets or from random subsets of the same size (corrected p >= 0.56), and its selected features were no more consistent across seeds than random ones. LASER-VFL failed on all features at a learning rate of 1e-3 but matched the other methods at 1e-4. This version corrects versions 1-3 of this preprint, which reported that standard VFL performed at chance and that domain priors stabilised training; we show that those results arose because every model selected its checkpoint on a single-sample validation set, which evaluated the baseline after one optimiser step. With very few samples, evaluation choices outweighed every method choice we tested, and we give recommendations for evaluating federated models in this regime.

q-bio.QM↗